![Jason Coloma](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jason Coloma
Direktor/Vorstandsmitglied bei Alloy Therapeutics LLC
Aktive Positionen von Jason Coloma
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Alloy Therapeutics LLC
![]() Alloy Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Alloy Therapeutics LLC is a biotechnology ecosystem company that democratizes access to tools, technologies, services, and company creation capabilities for discovering and developing therapeutic biologics. The company's lead offering is the ATX-GX™ platform, a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains. Through a community of partners across academia, biotech, and the largest biopharma, Alloy is a leader in bispecific antibody discovery and engineering services, utilizing its proprietary ATX-CLC common light chain platform integrating novel transgenic mice and phage display. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Hanover, NH, with European labs in Switzerland. The company was founded by Errik B. Anderson, who has been the CEO since incorporation. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Jason Coloma
Ausbildung von Jason Coloma
University of California, Berkeley | Doctorate Degree |
Tuck School of Business at Dartmouth | Masters Business Admin |
University of San Francisco | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Doctorate Degree | 1 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Sektoral
Consumer Services | 4 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Alloy Therapeutics LLC
![]() Alloy Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Alloy Therapeutics LLC is a biotechnology ecosystem company that democratizes access to tools, technologies, services, and company creation capabilities for discovering and developing therapeutic biologics. The company's lead offering is the ATX-GX™ platform, a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains. Through a community of partners across academia, biotech, and the largest biopharma, Alloy is a leader in bispecific antibody discovery and engineering services, utilizing its proprietary ATX-CLC common light chain platform integrating novel transgenic mice and phage display. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Hanover, NH, with European labs in Switzerland. The company was founded by Errik B. Anderson, who has been the CEO since incorporation. | Commercial Services |
- Börse
- Insiders
- Jason Coloma
- Erfahrung